Have a personal or library account? Click to login
Optimal anticoagulation strategy for atrial fibrillation ablation: are all direct oral anticoagulants and vitamin K antagonists the same? - a meta-analysis of embolic and bleeding complications in more than 31,500 patients Cover

Optimal anticoagulation strategy for atrial fibrillation ablation: are all direct oral anticoagulants and vitamin K antagonists the same? - a meta-analysis of embolic and bleeding complications in more than 31,500 patients

Romanian Journal of Cardiology
Volume 35 (2025): Issue 2 (June 2025)
By: Dan L Musat,  Bogdan Enache,  Alexandra Musat,  Advay Bhatt,  Mohammadali Habibi,  Stephanie Kochav,  Tina Sichrovsky,  Mark W Preminger and  Suneet Mittal  
Open Access
|Jun 2025

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/rjc-2025-0018 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Journal RSS Feed
Language: English
Page range: 104 - 122
Published on: Jun 26, 2025
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
atrial fibrillation,
dabigatran,
rivaroxaban,
apixaban,
edoxaban,
DOACS,
NOAC,
warfarin,
Coumadin,
phenprocoumon,
acenocoumarol,
VKA,
vitamin K antagonists,
atrial fibrillation ablation,
pulmonary vein isolation
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Surgery,
Cardiac surgery,
Pediatrics and juvenile medicine,
Paediatric cardiology

© 2025 Dan L Musat, Bogdan Enache, Alexandra Musat, Advay Bhatt, Mohammadali Habibi, Stephanie Kochav, Tina Sichrovsky, Mark W Preminger, Suneet Mittal, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 35 (2025): Issue 2 (June 2025)Next article